Authors:
MINTO CF
SCHNIDER TW
EGAN TD
YOUNGS E
LEMMENS HJM
GAMBUS PL
BILLARD V
HOKE JF
MOORE KHP
HERMANN DJ
MUIR KT
MANDEMA JW
SHAFER SL
Citation: Cf. Minto et al., INFLUENCE OF AGE AND GENDER ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF REMIFENTANIL .1. MODEL DEVELOPMENT, Anesthesiology, 86(1), 1997, pp. 10-23
Authors:
FIGG WD
DUKES GE
PRITCHARD JF
HERMANN DJ
LESESNE HR
CARSON SW
SONGER SS
POWELL R
HAK LJ
Citation: Wd. Figg et al., PHARMACOKINETICS OF ONDANSETRON IN PATIENTS WITH HEPATIC INSUFFICIENCY, Journal of clinical pharmacology, 36(3), 1996, pp. 206-215
Citation: Dj. Hermann et al., EFFECTS OF GI198745 (GG745), A NOVEL 5-ALPHA REDUCTASE (5AR) INHIBITOR, ON DIHYDROTESTOSTERONE (DHT), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 18-18
Citation: Ad. Killian et al., POPULATION PHARMACOKINETICS (PPK) OF TOBRAMYCIN (T) IN ADULTS WITH LEUKEMIA, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 69-69
Authors:
EGAN TD
MINTO CF
HERMANN DJ
BARR J
MUIR KT
SHAFER SL
Citation: Td. Egan et al., REMIFENTANIL VERSUS ALFENTANIL - COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY ADULT MALE-VOLUNTEERS, Anesthesiology, 84(4), 1996, pp. 821-833
Authors:
FIGG WD
DUKES GE
LESESNE HR
CARSON SW
SONGER SS
PRITCHARD JF
HERMANN DJ
POWELL JR
HAK LJ
Citation: Wd. Figg et al., COMPARISON OF QUANTITATIVE METHODS TO ASSESS HEPATIC-FUNCTION - PUGHSCLASSIFICATION, INDOCYANINE GREEN, ANTIPYRINE, AND DEXTROMETHORPHAN, Pharmacotherapy, 15(6), 1995, pp. 693-700
Authors:
EGAN TD
LEMMENS HJM
FISET P
HERMANN DJ
MUIR KT
STANSKI DR
SHAFER SL
Citation: Td. Egan et al., THE PHARMACOKINETICS OF THE NEW SHORT-ACTING OPIOID REMIFENTANIL (GI87084B) IN HEALTHY ADULT MALE-VOLUNTEERS, Anesthesiology, 79(5), 1993, pp. 881-892
Authors:
GLASS PSA
KAPILA A
MUIR KT
HERMANN DJ
SHIRAISHI M
Citation: Psa. Glass et al., A MODEL TO DETERMINE THE RELATIVE POTENCY OF MU OPIOIDS - ALFENTANIL VERSUS REMIFENTANIL, Anesthesiology, 79(3A), 1993, pp. 10000378-10000378